DT
Talabot Frischknecht-Ayer, Dominique
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in mice | Frontiers in immunology | 2024 | 35 | 11 | |||
Oxidation-sensitive cysteines drive IL-38 amyloid formation | Cell reports | 2024 | 16 | 6 | |||
IL ‐38 orchestrates proliferation and differentiation in human keratinocytes | Experimental dermatology | 2022 | 197 | 137 | |||
Epigenetic remodeling of downstream enhancer regions is linked to selective expression of the IL1F10 gene in differentiated human keratinocytes | Gene | 2022 | 189 | 105 | |||
Interleukin-38 interacts with destrin/actin-depolymerizing factor in human keratinocytes | PLOS ONE | 2019 | 308 | 135 | |||
The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression | PLOS ONE | 2018 | 459 | 223 | |||
Deficiency in IL-1 Receptor Type 2 Aggravates K/BxN Serum Transfer-Induced Arthritis in Mice but Has No Impact on Systemic Inflammatory Responses | Journal of Immunology | 2017 | 705 | 2 | |||
Severe Neutrophil-Dominated Inflammation and Enhanced Myelopoiesis in IL-33-Overexpressing CMV/IL33 Mice | The Journal of immunology | 2015 | 627 | 2 | |||
Immune-mediated experimental arthritis in IL-33 deficient mice | Cytokine | 2014 | 610 | 0 | |||
Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis | Joint bone spine | 2012 | 675 | 632 | |||
The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters | Journal of leukocyte biology | 2012 | 618 | 0 | |||
Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice | Annals of the rheumatic diseases | 2012 | 611 | 0 | |||
IL-36R ligands are potent regulators of dendritic and T cells | Blood | 2011 | 600 | 0 | |||
Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis | Arthritis and rheumatism | 2009 | 612 | 0 | |||
Interleukin-33 is biologically active independently of caspase-1 cleavage | The Journal of biological chemistry | 2009 | 595 | 463 | |||
The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33 | Cytokine | 2008 | 630 | 0 | |||
Expression and function of junctional adhesion molecule-C in human and experimental arthritis | Arthritis research & therapy | 2007 | 591 | 317 | |||
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells | Cytokine | 2007 | 470 | 0 | |||
Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice | Arthritis research & therapy | 2004 | 431 | 149 |